These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31335361)

  • 21. Pregnancy outcome in cases of intrahepatic cholestasis of pregnancy.
    Baliutavičienė D; Zubruvienė N; Zalinkevičius R
    Int J Gynaecol Obstet; 2011 Mar; 112(3):250-1. PubMed ID: 21247575
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic cholestasis.
    Jansen PL; Sturm E
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S107-9. PubMed ID: 12817339
    [No Abstract]   [Full Text] [Related]  

  • 25. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
    Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
    J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy.
    Nicastri PL; Diaferia A; Tartagni M; Loizzi P; Fanelli M
    Br J Obstet Gynaecol; 1998 Nov; 105(11):1205-7. PubMed ID: 9853771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gradual improvement of liver function after administration of ursodeoxycholic acid in an infant with a novel ABCB11 gene mutation with phenotypic continuum between BRIC2 and PFIC2.
    Takahashi A; Hasegawa M; Sumazaki R; Suzuki M; Toki F; Suehiro T; Onigata K; Tomomasa T; Suzuki T; Matsui A; Morikawa A; Kuwano H
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):942-6. PubMed ID: 18049162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.
    Deng BC; Lv S; Cui W; Zhao R; Lu X; Wu J; Liu P
    World J Gastroenterol; 2012 Nov; 18(44):6504-9. PubMed ID: 23197899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.
    Lykavieris P; Bernard O; Jacquemin E
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101472. PubMed ID: 32565202
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
    Brites D; Rodrigues CM
    J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
    Bacq Y; le Besco M; Lecuyer AI; Gendrot C; Potin J; Andres CR; Aubourg A
    Dig Liver Dis; 2017 Jan; 49(1):63-69. PubMed ID: 27825922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
    Mörk H; al-Taie O; Klinge O; Scheurlen M
    Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic cholestasis of pregnancy: a case report.
    Konjeti R; Selsky N
    Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
    Huynh MT; Nguyen TT; Grison S; Lascols O; Fernandez E; Barbu V
    Rev Esp Enferm Dig; 2019 Oct; 111(10):775-788. PubMed ID: 31538484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G; Fehér R; Gardó S; Fehér J
    Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.